KemPharm, Inc. - stock earnings
Stock symbol KMPH is outdated, potentially delisted? Maybe it is available on other exchange?
KMPH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | -6.6 million USD | 2.9 million USD |
| 2022Q2 | -24.0 million USD | 1.3 million USD |
| 2022Q1 | -1.9 million USD | 4.0 million USD |
| 2021Q4 | -2.7 million USD | 2.6 million USD |
| 2021Q3 | -1.8 million USD | 2.0 million USD |
| 2021Q2 | 6.2 million USD | 12.0 million USD |
| 2021Q1 | -10.3 million USD | 12.1 million USD |
| 2020Q4 | -4.9 million USD | 2.4 million USD |
| 2020Q3 | -3.0 million USD | 1.9 million USD |
KMPH Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -8.6 million USD | 28.7 million USD |
| 2020 | -12.8 million USD | 13.3 million USD |
| 2019 | -24.5 million USD | 12.8 million USD |
| 2018 | -56.5 million USD | ? USD |
| 2017 | -43.4 million USD | ? USD |
KMPH
Price: $5.81
52 week price:
Earnings Per Share: -0.68 USD
P/E Ratio: 17.60
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 175000
Ebitda: -8.1 millionMarket Capitalization: 200.5 million